These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25750554)

  • 21. Recent advances in pediatric rheumatology: October to December 2016.
    Gupta A; Kumar A; Singh S
    Int J Rheum Dis; 2018 Feb; 21(2):544-545. PubMed ID: 29045022
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent advances in pediatric rheumatology: July-September 2016.
    Singh S; Kumar A; Gupta A
    Int J Rheum Dis; 2018 Feb; 21(2):541-543. PubMed ID: 27885816
    [No Abstract]   [Full Text] [Related]  

  • 23. S100 proteins in rheumatic diseases.
    Austermann J; Spiekermann C; Roth J
    Nat Rev Rheumatol; 2018 Sep; 14(9):528-541. PubMed ID: 30076385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
    Ferraccioli G; De Santis M; Tolusso B
    Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of the Institute of Rheumatology in formation and development of State controlling system of rheumatic diseases].
    Folomeeva OM; Amirdzhanova VN
    Vestn Ross Akad Med Nauk; 1998; (12):9-12. PubMed ID: 9987951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Approaches to Understanding the Pathogenic Role of Genetic Variation in Rheumatic Diseases.
    Laufer VA; Chen JY; Langefeld CD; Bridges SL
    Rheum Dis Clin North Am; 2017 Aug; 43(3):449-466. PubMed ID: 28711145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatologic rehabilitation: the great expectation for rheumatic patients.
    Maddali Bongi S; Matucci Cerinic M
    Reumatismo; 2012 Mar; 64(1):1-6. PubMed ID: 22472777
    [No Abstract]   [Full Text] [Related]  

  • 29. Complexities in defining remission in rheumatic diseases.
    Pincus T; Kavanaugh A; Aletaha D; Smolen J
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-1-6. PubMed ID: 17083755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects.
    Setty AR; Sigal LH
    Semin Arthritis Rheum; 2005 Jun; 34(6):773-84. PubMed ID: 15942912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treat-to-target in rheumatology].
    Majdan M
    Wiad Lek; 2015; 68(3):259-64. PubMed ID: 26753210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetic of antirheumatic treatments: clinical implications.
    Ferraccioli G; Tolusso B; De Santis M
    Pharmacogenomics J; 2007 Feb; 7(1):2-9. PubMed ID: 16702980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods for measuring patient preferences: an update and future directions.
    Meara A; Crossnohere NL; Bridges JFP
    Curr Opin Rheumatol; 2019 Mar; 31(2):125-131. PubMed ID: 30624283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor necrosis factor therapies in immune-mediated rheumatic diseases. Other observations from the clinic.
    Russell AS; Rosenbaum JT
    J Rheumatol Suppl; 2010 May; 85():53-62. PubMed ID: 20436165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug response.
    Asanuma Y; Xie HG; Stein CM
    Arthritis Rheum; 2005 May; 52(5):1349-59. PubMed ID: 15880820
    [No Abstract]   [Full Text] [Related]  

  • 36. [An era of international collaboration in pediatric rheumatology].
    Uziel Y; Hashkes P
    Harefuah; 2011 Sep; 150(9):737-41, 749. PubMed ID: 22026061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the American College of Rheumatology's Electronic Health Record-Enabled Registry: The Rheumatology Informatics System for Effectiveness.
    Francisco M; Johansson T; Kazi S
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S102-S104. PubMed ID: 27762205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DANBIO: a nationwide registry of biological therapies in Denmark.
    Hetland ML
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S205-7. PubMed ID: 16273809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A brief introduction to the National Data Bank for Rheumatic Diseases.
    Wolfe F; Michaud K
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S168-71. PubMed ID: 16273802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OPAL: a clinician driven point of care observational data management consortium.
    Tymms K; Littlejohn G
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-150-2. PubMed ID: 25365106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.